Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
The gene CACNA1C is among the best replicated vulnerability genes of bipolar disorder and schizophrenia.
|
26475575 |
2015 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A history of suicide attempt was assessed in a sample of 1009 patients with BD, SCZ and related psychosis spectrum disorders, and associations with the joint genetic risk variants for BD and SCZ (rs2239547 (ITIH3/4-region), rs10994359 (ANK3) and rs4765905 (CACNA1C)) were investigated.
|
24461634 |
2014 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
GWASCAT |
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
|
24280982 |
2014 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
Genes Involved in Neurodevelopment, Neuroplasticity, and Bipolar Disorder: CACNA1C, CHRNA1, and MAPK1.
|
28494468 |
2016 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
Developments in genotyping technology and efforts to combine data from different studies have helped in identifying chromosomes 6q16-q25, 13q, and 16p12 as probable susceptibility loci for bipolar disorder and confirmed CACNA1C and ANK3 as susceptibility genes for bipolar disorder.
|
21837483 |
2011 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
The GWAS-based association of CACNA1C with bipolar disorder (BPD) is one of the strongest genetic findings to date.
|
22488967 |
2012 |
Bipolar Disorder
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
In treatment of BD with calcium channel blocking drugs, we would predict better response in patients without the risk allele, because they have increased CACNA1C expression.
|
23979604 |
2014 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
GWASCAT |
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.
|
18711365 |
2008 |
Bipolar Disorder
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
We also found unprecedented evidence for epistasis (interaction between genetic polymorphisms) in the caudate nucleus, thalamus, and cingulate and temporal cortical activation; and CACNA1C up-regulation in SCZ and BD parietal cortices.
|
30079586 |
2019 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
GWASCAT |
Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression.
|
30626913 |
2019 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies 30 loci associated with bipolar disorder.
|
31043756 |
2019 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The ZNF804A and CACNA1C loci appear to influence risk for both disorders, a finding that supports the hypothesis that schizophrenia and BD are not aetiologically distinct.
|
19521722 |
2009 |
Bipolar Disorder
|
0.700 |
PosttranslationalModification
|
disease |
BEFREE |
CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder.
|
26541689 |
2016 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CACNA1C polymorphisms Impact Cognitive Recovery in Patients with Bipolar Disorder in a Six-week Open-label Trial.
|
28765577 |
2017 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
First, the methylation status of five CpG islands (CGIs) across CACNA1C in blood from BD subjects (n=40) and healthy controls (n=38) was determined.
|
27271857 |
2016 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
Strong genetic associations have been reported at common polymorphisms within ANK3 and CACNA1C in bipolar disorder and ZNF804A in schizophrenia and a relatively specific association between common variation in GABA(A) receptor genes and cases with features of both bipolar disorder and schizophrenia.
|
19329560 |
2009 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The risk-associated SNP in CACNA1C maps to circuitries implicated in genetic risk for bipolar disorder and schizophrenia.
|
20819988 |
2010 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This sheds light on links between CACNA1C genetic variants and pathophysiological mechanisms in bipolar disorder.Declaration of interestNone.
|
31317860 |
2019 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, polymorphisms in CACNA1C and SYNE1 could confer a greater risk of developing SZ and BD in individuals who are already at high risk because of their family history.
|
27620326 |
2016 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Our study further supports the association of SNP rs1006737 with BD-I and suggests that CACNA1C SNP rs1006737 and Bcl-2 SNP rs956572, or specific causal variants in LD with these proxies, act independently to increase risk and ICDH in BD-I.
|
25843436 |
2016 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Recent genetic studies found the A allele of the variant rs1006737 in the alpha 1C subunit of the L-type voltage-gated calcium channel (CACNA1C) gene to be over-represented in patients with psychosis, including schizophrenia, bipolar disorder and major depressive disorder.
|
21078228 |
2011 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
In treatment of BD with calcium channel blocking drugs, we would predict better response in patients without the risk allele, because they have increased CACNA1C expression.
|
23979604 |
2014 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The rs10994336 ANK3 and rs1006737 CACNA1C genetic variants have recently been identified as the most consistent, genome-wide significant risk factors for bipolar disorder, while the CACNA1C variant has also been associated with schizophrenia and major depression.
|
21676128 |
2011 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
On the other hand, our results indicate that alterations in the functional coupling between the prefrontal cortex and the medial temporal lobe could represent a neural system phenotype that is mediated by CACNA1C rs1006737 and other genetic susceptibility loci for schizophrenia and bipolar disorder.
|
23404764 |
2014 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |